Bookmark and Share

Last Minute:          For more news, click here.

Remember me? 

PS: The quotes after 2018-12-04 are still temporary and may have for that reason the Open values wrong until furter updates...
Change to Pfizer Static Chart

Fall of
--0.85 (+0.98%) Pfizer - [Ticker: PFE]Chart Pfizer  News Pfizer  Download Historical Prices for Metastock Pfizer and Others  Technical Analysis Pfizer  
Last Trade45.14Last Trade Time2018-12-04 - 00:00:00
Variation--0.85 (+0.98%)Open46.23
Volume26,062,310Average Volume (3m)0
YieldBid / Ask35.33 x 5,700 - 35.34 x 8,100
Former Close45.9952 Week Range[0.00 - 0.00]
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.

 News about Pfizer [PFE]:   (ordered by relevance)
  1. Pfizer CEO confident Covid treatment pill will be effective against omicron variant  CNBC
  2. Pfizer CEO: We?re working on vaccine for Omicron; our pill will also be effective  The Times of Israel
  3. From Pfizer to Moderna: What vaccine makers are saying about omicron jabs  Hindustan Times
  4. Pfizer's Pill, Shot Push Stock to Record as Variant Emerges  Bloomberg
  5. Moderna, Pfizer, J&J talk omicron response  Fox Business
  1. Pfizer expected to seek FDA authorization for boosters for those ages 16 and 17  CNN
  2. FDA Moving to Authorize Pfizer-BioNTech Booster for 16-, 17-Year-Olds  The Wall Street Journal
  3. Pfizer set to request authorization for coronavirus booster for 16- and 17-year-olds  The Washington Post
  4. Pfizer Reportedly Plans To Ask For Approval Of Covid Boosters For 16- And 17-Year-Olds  Forbes
  5. U.S. FDA moving to authorize Pfizer-BioNTech booster for 16-, 17-year-olds - WSJ  Reuters
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study  Pfizer Pfizer now expects to produce 80 mln courses of COVID-19 pill, CEO tells CNBC  Reuters Fact check: New ingredient in Pfizer COVID-19 vaccine mischaracterized in online posts  USA TODAY Pfizer Is Lobbying to Thwart Whistleblowers Exposing Fraud  The Intercept Balance of Power: Pfizer CEO on Omicron Vaccine (Radio)  Bloomberg Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age  Pfizer Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATYŽ in Children 5 to  Pfizer Pfizer CEO on Omicron Covid-19 Variant, Vaccine Supply  Bloomberg Omicron: All UK adults to get Pfizer or Moderna booster  Proactive Investors UK Investing in Pfizer Stock (PFE)  Investopedia Wall Street Covid Fears Ease, Retail Outlook, Pfizer  Bloomberg Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week  Motley Fool Will Pfizer Stock Continue To Rise?  Forbes Pfizer expects to produce 80 mln courses of COVID-19 antiviral pill  The Jerusalem Post Pfizer raises Covid-19 vaccine sales forecast to $36bn for 2021  The Guardian Pfizer says former employee stole trade secrets on megablockbuster COVID-19 vaccine  FiercePharma Ranok Therapeutics Announces Agreement with Pfizer on Targeted Protein Degradation  BioSpace Omicron: Pfizer, BioNTech and Moderna race to tweak Covid vaccines against new Coronavirus variant  City A.M. Pfizer and BioNTech Receive Expanded US FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older  Pfizer 234,000 doses of Pfizer vaccine released following intensive testing  The Libya Observer S. Africa Wants J&J, Pfizer Vaccine Delivery Delay, News24 Says  Bloomberg Egypt authorizes Pfizer's COVID-19 vaccine for 12 to 15 year-olds  Reuters Moderna, Pfizer, and Adagio likely to benefit from Omicron variant - Morgan Stanley  Seeking Alpha Covid-19: New research reveals Pfizer is making misleading claims about fair distribution of vaccines  Amnesty International Coronavirus: Pfizer jabs for 5-11 years old by December 20  Cyprus Mail New Kent County High School to hold Pfizer COVID-19 vaccine clinic for children ages 5-11  WWBT NBC12 News Why Pfizer Rose While the Market Sank on Wednesday  Motley Fool Pfizer marks World Antimicrobial Awareness Week  P.M. News Pfizer Covid Vaccine Generated Most Antibodies in Comparative Study  Bloomberg CDC backs Pfizer Covid-19 vaccine for young children  The Guardian Thinking about trading options or stock in Pfizer, American Airlines, Krystal Biotech, NVIDIA, or Alibaba?  PRNewswire Exact Sciences ends co-promotion deal with Pfizer for Cologuard  Seeking Alpha Pfizer: Bull vs. Bear  Motley Fool Zipline, Pfizer and BioNTech Collaboration Paves the Way for Automated, On-Demand Delivery of First mRNA COVID-19 Vaccines in Ghana  Pfizer Stocks making the biggest moves in the premarket: Pfizer, Under Armour, Generac and more  CNBC Pfizer Vaccine Supplies Dwindle in Germany  The New York Times S.Korea to purchase 70000 courses of new Pfizer COVID-19 pill  Reuters Pre-Market Most Active for Nov 29, 2021 : NRXP, SQQQ, PFE, CCL, MRNA, AAPL, LI, AAL, RLX, NIO, NCLH, F  Nasdaq MRNA, PFE, BNTX, FSR, NVAX: Which Stocks are Trending Today 29 Nov?  Value The Markets Covid-19 vaccine: UAE announces Pfizer, Sputnik booster shots for all eligible adults  Khaleej Times Germany recommends only Biontech/Pfizer vaccine for under-30s  Reuters High Doses Of Dividend Growth Expected From Pfizer, Eli Lilly, Bristol Myers In December  Seeking Alpha Rutgers Expanding Enrollment for Pfizer COVID-19 Pediatric Vaccine Trial Pfizer board member Gottlieb says the Covid pandemic could be over in the U.S. by January  CNBC An Intrinsic Calculation For Pfizer Inc. (NYSE:PFE) Suggests It's 50% Undervalued  Nasdaq Bitcoin reverses ?bear market? at $53.5K as Pfizer gains on fresh panic over coronavirus ?Nu? variant  Cointelegraph Strength of COVID-19 antibodies depends on age and sex, study finds  Daily Mail Health Care District of Palm Beach County continues to offer Pfizer vaccines across school district  WPBF West Palm Beach President Biden Says Medical Team Believes Vaccines Provide Protection; Says Team Is Working With Moderna, Pfizer On Contingency Plan  Benzinga Pfizer gene therapy research delayed by trial changes, safety questions  BioPharma Dive Covid News: Los Angeles Businesses Grapple With Vaccine Mandate  The New York Times Pfizer Stock Active After CFO Retirement, FDA Application For COVID Pill Approval  TheStreet Covid Updates: Pfizer Says Its Antiviral Pill Is Highly Effective  The New York Times Covid News: D.C. Eases Indoor Mask Restrictions  The New York Times Long-term effectiveness of Pfizer/BioNTech two-dose regimen mRNA vaccine Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age | NEJM Elizabeth Holmes cross-examination: 'The devil will be in the details'  Yahoo Finance FDA authorizes booster dose of Pfizer's Covid-19 vaccine for people 65 and older  CNN Here?s Why Pfizer Stock Can Rebound After Falling Nearly 15% From Its Peak Last Month  Forbes Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years  Pfizer Pfizer-BioNTech COVID-19 Vaccine COMIRNATYŽ Receives Full US FDA Approval for Individuals 16 Years and Older  Pfizer Pfizer accused of holding Brazil ?to ransom? over vaccine contract demands  The Guardian Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study  Pfizer Freedom of Information request on REG 174 for Pfizer COVID-19 mRNA vaccine (FOI 21-611)  GOV.UK Pfizer plans to file for full FDA approval of Covid vaccine at the end of this month  CNBC Pfizer and Flynn accused of overcharging NHS for anti-epilepsy drugs  The Guardian Pfizer Covid jab ?90% effective against hospitalisation for at least 6 months?  The Guardian Real-World Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared  Pfizer Pfizer and BioNTech Announce Submission of Initial Data to US FDA to Support Booster Dose of COVID-19 Vaccine  Pfizer Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study  Pfizer First real-world UK data shows Pfizer-BioNTech vaccine provides high levels of protection from the first dose  GOV.UK Covid-19: Pfizer vaccine's efficacy declined from 96% to 84% four months after second dose, company reports  The BMJ Summary of Product Characteristics for COVID-19 Vaccine Pfizer/BioNTech  GOV.UK Pfizer Submits Favorable Initial Data To The FDA On Kids' COVID-19 Vaccine Trial  NPR FactCheck: what are the safety risks of the Pfizer vaccine?  Channel 4 News Patient Information Leaflet for COVID-19 Vaccine Pfizer/BioNTech  GOV.UK Pfizer/BioNTech COVID-19 vaccine shelf-life extended from 5 to 31 days, says MHRA  GOV.UK Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the US FDA  Pfizer Pfizer and BioNTech Expand Collaboration with US to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-for-Profit Price for Donation to Poorest Countries  Pfizer Pfizer and BioNTech Announce Collaboration With Brazil's Eurofarma to Manufacture COVID-19 Vaccine Doses for Latin America  Pfizer Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for Post-Exposure Prophylaxis in Adults  Pfizer Pfizer raises sales forecast for Covid vaccine by almost a third to $33bn  Financial Times Covid-19: FDA set to grant full approval to Pfizer vaccine without public discussion of data  The BMJ Pfizer CEO says third Covid vaccine dose likely needed within 12 months  CNBC Australia shores up Pfizer supply after days of uncertainty  The Guardian Pfizer to Acquire Trillium Therapeutics Inc.  Pfizer Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for US FDA Approval of Their COVID 19 Vaccine  Pfizer Pfizer vaccine effectiveness declines faster than AstraZeneca ? study  Evening Standard Pfizer and Moderna investors brace for eventual drop in vaccine sales  Financial Times Is Pfizer Stock Set To See Higher Levels Post Q2 Results?  Forbes MHRA statement on booster doses of Pfizer and AstraZeneca COVID-19 vaccines  GOV.UK Here's Why Pfizer Stock Can Rebound After Falling Nearly 15% From Its Peak Last Month  Nasdaq Floating material found in Pfizer COVID-19 vaccine vials in Japan, but company says it's not contamination  FiercePharma Boys more at risk from Pfizer jab side-effect than Covid, suggests study  The Guardian Pfizer Declares Fourth-Quarter 2021 Dividend  Pfizer Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants  Pfizer Pfizer (PFE) Shot's Protection Against Hospitalization Wanes in Study  Bloomberg Pfizer Announces Start of Phase 3 Clinical Trial in Adults for Its Investigational Vaccine Against Respiratory Syncytial Virus (RSV)  Pfizer
For more news about Pfizer click here:
Pfizer News 

Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2021 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources